Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Internal Medicine
Volume 21 (2024): Issue 2 (June 2024)
Open Access
The Impact on the Quality of Life of Patients with Drug-Resistant Tuberculosis – Brief Review
Teodora Butnaru
Teodora Butnaru
University of Medicine and Pharmacy “Carol Davila”
Bucharest,
“Marius Nasta” Institute of Pneumology
Bucharest,
Search for this author on
Sciendo
|
Google Scholar
Butnaru, Teodora
,
Florin Dumitru Mihălţan
Florin Dumitru Mihălţan
University of Medicine and Pharmacy “Carol Davila”
Bucharest,
“Marius Nasta” Institute of Pneumology
Bucharest,
Search for this author on
Sciendo
|
Google Scholar
Mihălţan, Florin Dumitru
and
Constantin Ancuţa
Constantin Ancuţa
University of Medicine and Pharmacy “Carol Davila”
Bucharest,
“Marius Nasta” Institute of Pneumology
Bucharest,
Search for this author on
Sciendo
|
Google Scholar
Ancuţa, Constantin
Jun 12, 2024
Internal Medicine
Volume 21 (2024): Issue 2 (June 2024)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Jun 12, 2024
Page range:
65 - 78
DOI:
https://doi.org/10.2478/inmed-2024-0289
Keywords
tuberculosis
,
multidrug resistance
,
quality of life
© 2024 Teodora Butnaru et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.